Drug Safety remains a key topic as the regulatory landscape evolves to meet the demands of scientific innovation. In our ninth year, we will be covering the latest technological developments in drug safety including integration, data source, signal detection, safety analytics and regulation. Topics under discussion in 2017 include the use of social media to support risk management practices, applying fresh thinking to signal management challenges, outsourcing vs. in-house clinical data management and achieving collaboration between pharmacovigilance and technology. World Drug Safety Congress Americas is the meeting place of global pioneers who are shaping the pharmacovigilance industry.
Join us on Day 1 as David Balderson, Vice President of Safety Operations, Sciformix Corporation will be giving a presentation on “Pharmacovigilance Prioritization across the product lifecycle: An analysis of how PV can be managed differently for smaller companies with products in development versus larger companies with a diverse portfolio”.